Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra

Regional neuronal loss in the substantia nigra was studied in relation to extrapyramidal symptoms and dementia in 12 patients with idiopathic Parkinson's disease(PD) and in 18 control subjects. Four areas of the right substantia nigra were investigated at the level of the superior colliculus and caudal red nucleus. In Parkinson's disease, the percentages of neurons, from the medial to the lateral part of the substantia nigra, were reduced to 49°, 31°, 41°, and 25° of the control values. The number of neurons in the lateral part showed a negative correlation with the severity of rigidity and hypokinesia, whereas tremor was less noticeable in patients with few neurons. The degree of dementia of the patients had a significant correlation only with neuronal loss in the medial part of the substantia nigra, suggesting, in view of the topographical organization of the neurons in the substantia nigra, that intact projections to the caudate nucleus and limbic and cortical areas are a prerequisite for normal cognitive functioning and that their dysfunction leads to clinical dementia.

[1]  J. Morris,et al.  The association of ventral tegmental area histopathology with adult dementia. , 1988, Archives of neurology.

[2]  C. Marsden,et al.  'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. , 1988, Brain : a journal of neurology.

[3]  G. Geffen,et al.  Catecholamines and attention I: Animal and clinical studies , 1987, Neuroscience & Biobehavioral Reviews.

[4]  J. Rinne,et al.  Alzheimer's disease: neuropathological correlates of cognitive and motor disorders , 1987, Acta neurologica Scandinavica.

[5]  R. Oades,et al.  Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity , 1987, Brain Research Reviews.

[6]  J. Saint-Cyr,et al.  Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. , 1986, Brain : a journal of neurology.

[7]  D L Price,et al.  Parkinson's disease , 1985, Neurology.

[8]  B. Reisberg.  Alzheimer's Disease Update , 1985 .

[9]  R. Wurtz,et al.  Behavioral correlates of activity in basal ganglia neurons , 1984, Trends in Neurosciences.

[10]  I. Nakano,et al.  Parhnson’s Disease: Neuron Loss in the Nucleus Basah Without Concomitant Alzheimer’s Disease , 2004 .

[11]  L. Ronnevi,et al.  Increased fragility of erythrocytes from amyotrophic lateral sclerosis (ALS) patients provoked by mechanical stress , 1984, Acta neurologica Scandinavica.

[12]  Y. Agid,et al.  Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease , 1983, Brain Research.

[13]  D L Price,et al.  Basal forebrain neurons in the dementia of Parkinson disease , 1983, Annals of neurology.

[14]  M. Kuskowski,et al.  Dementia in Parkinson disease: A neuropsychological analysis , 1982, Brain and Cognition.

[15]  Y. Agid,et al.  Distribution of Catecholamines in the Ventral Mesencephalon of Human Brain, with Special Reference to Parkinson's Disease , 1981, Journal of neurochemistry.

[16]  H. Simon,et al.  Dopaminergic A10 neurones are involved in cognitive functions , 1980, Nature.

[17]  M. Kupersmith,et al.  Dementia in Parkinson disease , 1979, Annals of neurology.

[18]  G. Bots,et al.  Viral meningoencephalitis and head injury , 1978, Acta neurologica Scandinavica.

[19]  H. Gundersen,et al.  Notes on the estimation of the numerical density of arbitrary profiles: the edge effect , 1977 .

[20]  R. Marttila,et al.  DEMENTIA IN PARKINSON'S DISEASE , 1976, Acta neurologica Scandinavica.

[21]  K. Jellinger,et al.  Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.

[22]  U. Rinne,et al.  Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease , 1972, Neurology.

[23]  F. Puletti,et al.  Personality (MMPI) and cognitive (WAIS) changes after levodopa treatment. , 1971, Archives of neurology.

[24]  P. Bédard,et al.  Correlative neuroanatomical and neuropharmacological study of tremor and catatonia in the monkey. , 1971, Neuropharmacology.

[25]  Cummings Jl.  The dementias of Parkinson's disease: prevalence, characteristics, neurobiology, and comparison with dementia of the Alzheimer type. , 1988 .

[26]  S J Kish,et al.  Biochemical pathophysiology of Parkinson's disease. , 1987, Advances in neurology.

[27]  K. Jellinger,et al.  Overview of morphological changes in Parkinson's disease. , 1987, Advances in neurology.

[28]  Hassler Rg.  Chairman's introduction: role of the pallidum and its transmitters in the therapy of parkinsonian rigidity and akinesia. , 1984, Advances in neurology.

[29]  F E Bloom,et al.  Central catecholamine neuron systems: anatomy and physiology of the dopamine systems. , 1978, Annual review of neuroscience.

[30]  F. Mcdowell,et al.  Intellectual impairment in Parkinson's syndrome. , 1972, Brain : a journal of neurology.

[31]  B. Djahanguiri,et al.  The prevention of acute gastric ulcer in the rat by alpha-methyldopa. , 1967, Medicina et pharmacologia experimentalis. International journal of experimental medicine.